Skip to main content
Top
Published in: Abdominal Radiology 4/2009

01-07-2009

Detecting recurrence of gastric cancer: the value of FDG PET/CT

Authors: Min Jung Park, Won Jae Lee, Hyo K. Lim, Ko Woon Park, Joon Young Choi, Byung-Tae Kim

Published in: Abdominal Radiology | Issue 4/2009

Login to get access

Abstract

Purpose

In order to assess the diagnostic performance of Positron emission tomography/Computed tomography (PET/CT) for detecting recurrence in gastric cancer patients with clinical or radiologic suspicion of recurrence after surgical resection.

Materials and methods

Over a 4-year period, 105 post-operative patients with gastric cancer, who underwent PET/CT due to clinical or radiologic suspicion of recurrence during follow-up, were collected after confirming their PET/CT findings. The number and site of positive FDG uptake were retrospectively analyzed, and were correlated with the final diagnosis, by calculating the diagnostic values and assessing the causes of misdiagnosis.

Results

Of all 105 patients, 75 patients were confirmed to have true recurrence with 108 recurrence sites. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy for diagnosing true recurrence on a per-person basis were 75%, 77%, 89%, 55%, and 75%, respectively. On a per-lesion basis, 75 (69%) of 108 true recurrences showed positive FDG uptake, while 75 (89%) of 84 positive FDG uptake was confirmed to have true recurrence.

Conclusion

PET/CT was relatively accurate in detecting recurrence in post-operative patients with gastric cancer. Moreover, PET/CT might be helpful in confirming the presence of recurrence particularly in patients who were highly suspicious of recurrence, because of its high positive predictability.
Literature
1.
go back to reference Schwarz RE, Zagala-Nevarez K (2002) Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol 9:394–400PubMedCrossRef Schwarz RE, Zagala-Nevarez K (2002) Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol 9:394–400PubMedCrossRef
2.
go back to reference Yoo CH, Noh SH, Shin DW et al (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236–242PubMedCrossRef Yoo CH, Noh SH, Shin DW et al (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236–242PubMedCrossRef
3.
go back to reference Kodera Y, Ito S, Yamamura Y et al (2003) Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefits. Ann Surg Oncol 10:898–902PubMedCrossRef Kodera Y, Ito S, Yamamura Y et al (2003) Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefits. Ann Surg Oncol 10:898–902PubMedCrossRef
4.
go back to reference Kim KW, Choi BI, Han JK et al (2002) Postoperative anatomic and pathologic findings at CT following gastrectomy. Radiographics 22:323–336PubMedCrossRef Kim KW, Choi BI, Han JK et al (2002) Postoperative anatomic and pathologic findings at CT following gastrectomy. Radiographics 22:323–336PubMedCrossRef
5.
go back to reference Ha HK, Kim HH, Kim HS et al (1993) Local recurrence after surgery for gastric carcinoma: CT findings. AJR Am J Roentgenol 161:975–977PubMed Ha HK, Kim HH, Kim HS et al (1993) Local recurrence after surgery for gastric carcinoma: CT findings. AJR Am J Roentgenol 161:975–977PubMed
6.
go back to reference Mullin D, Shirkhoda A (1985) Computed tomography after gastrectomy in primary gastric carcinoma. J Comput Assist Tomogr 9:30–33PubMedCrossRef Mullin D, Shirkhoda A (1985) Computed tomography after gastrectomy in primary gastric carcinoma. J Comput Assist Tomogr 9:30–33PubMedCrossRef
7.
go back to reference Kinkel K, Ly Y, Both M et al (2002) Detection of hepatic metastasis from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002:748–756CrossRef Kinkel K, Ly Y, Both M et al (2002) Detection of hepatic metastasis from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002:748–756CrossRef
8.
go back to reference Yoon YC, Lee KS, Shim YM et al (2003) Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection-prospective study. Radiology 227:764–770PubMedCrossRef Yoon YC, Lee KS, Shim YM et al (2003) Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection-prospective study. Radiology 227:764–770PubMedCrossRef
9.
go back to reference Flamen P, Lerut A, Van Cutsem E et al (2000) The utility of positron emission tomography (PET) for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 120:1085–1092PubMedCrossRef Flamen P, Lerut A, Van Cutsem E et al (2000) The utility of positron emission tomography (PET) for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 120:1085–1092PubMedCrossRef
10.
go back to reference Flamen P, Stroobants S, Van Cutsem E et al (1999) Additional value of whole-body positron emission tomography with fluorine-18–2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer. J Clin Oncol 17:894–901PubMed Flamen P, Stroobants S, Van Cutsem E et al (1999) Additional value of whole-body positron emission tomography with fluorine-18–2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer. J Clin Oncol 17:894–901PubMed
11.
go back to reference Yeung HW, Macapinlac H, Karpeh M et al (1998) Accuracy of FDG-PET in gastric cancer. Clin Positron Imaging 1:213–221PubMedCrossRef Yeung HW, Macapinlac H, Karpeh M et al (1998) Accuracy of FDG-PET in gastric cancer. Clin Positron Imaging 1:213–221PubMedCrossRef
12.
go back to reference Stahl A, Ott K, Weber WA et al (2001) Correlation of FDG uptake in gastric carcinomas with endoscopic and histopathological findings. J Nucl Med 42:78–79 Stahl A, Ott K, Weber WA et al (2001) Correlation of FDG uptake in gastric carcinomas with endoscopic and histopathological findings. J Nucl Med 42:78–79
13.
go back to reference Yun M, Lim JS, Noh SH et al (2005) Lymph node staging of gastric cancer using 18F-FDG PET: a comparison with CT. J Nucl Med 46:1582–1588PubMed Yun M, Lim JS, Noh SH et al (2005) Lymph node staging of gastric cancer using 18F-FDG PET: a comparison with CT. J Nucl Med 46:1582–1588PubMed
14.
go back to reference Mochiki E, Kuwano H, Katoh H et al (2004) Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg 24:247–253CrossRef Mochiki E, Kuwano H, Katoh H et al (2004) Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg 24:247–253CrossRef
15.
go back to reference Kim S-K, Kang KW, Lee JS et al (2006) Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 33:148–155PubMedCrossRef Kim S-K, Kang KW, Lee JS et al (2006) Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 33:148–155PubMedCrossRef
16.
go back to reference De Potter T, Flamen P, van Cutsem E et al (2002) Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging 29:525–529PubMedCrossRef De Potter T, Flamen P, van Cutsem E et al (2002) Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging 29:525–529PubMedCrossRef
17.
go back to reference Jadvar H, Tatlidil R, Garcia AA et al (2003) Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol 58:215–221PubMedCrossRef Jadvar H, Tatlidil R, Garcia AA et al (2003) Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol 58:215–221PubMedCrossRef
18.
go back to reference Lardinois D, Weder W, Hany TF et al (2003) Staging of non-small-cell lung cancer. N Engl J Med 348:2500–2507PubMedCrossRef Lardinois D, Weder W, Hany TF et al (2003) Staging of non-small-cell lung cancer. N Engl J Med 348:2500–2507PubMedCrossRef
19.
go back to reference Antoch G, Saoudi N, Kuehl H et al (2004) Accuracy of whole-body dual-modality fluorine-18–2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22:4357–4368PubMedCrossRef Antoch G, Saoudi N, Kuehl H et al (2004) Accuracy of whole-body dual-modality fluorine-18–2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22:4357–4368PubMedCrossRef
20.
go back to reference Keidar Z, Haim N, Guralnik L et al (2004) PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med 45:1640–1646PubMed Keidar Z, Haim N, Guralnik L et al (2004) PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med 45:1640–1646PubMed
21.
go back to reference Kamel IR, Cohade C, Neyman E et al (2004) Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging 29:663–668PubMedCrossRef Kamel IR, Cohade C, Neyman E et al (2004) Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging 29:663–668PubMedCrossRef
22.
go back to reference Reinartz P, Wieres F-J, Schneider W et al (2004) Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT? Eur J Nucl Med Mol Imaging 31:1456–1461PubMedCrossRef Reinartz P, Wieres F-J, Schneider W et al (2004) Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT? Eur J Nucl Med Mol Imaging 31:1456–1461PubMedCrossRef
23.
go back to reference Kostakoglu L, Hardoff R, Mirtcheva R et al (2004) PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 24:1411–1431PubMedCrossRef Kostakoglu L, Hardoff R, Mirtcheva R et al (2004) PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 24:1411–1431PubMedCrossRef
24.
go back to reference Blake MA, Singh A, Setty BN et al (2006) Pearls and pitfalls in interpretation of abdominal and pelvic PET-CT. Radiographics 26:1335–1353PubMedCrossRef Blake MA, Singh A, Setty BN et al (2006) Pearls and pitfalls in interpretation of abdominal and pelvic PET-CT. Radiographics 26:1335–1353PubMedCrossRef
25.
go back to reference Lim JS, Yun MJ, Kim M-J et al (2006) CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics 26:143–156PubMedCrossRef Lim JS, Yun MJ, Kim M-J et al (2006) CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics 26:143–156PubMedCrossRef
Metadata
Title
Detecting recurrence of gastric cancer: the value of FDG PET/CT
Authors
Min Jung Park
Won Jae Lee
Hyo K. Lim
Ko Woon Park
Joon Young Choi
Byung-Tae Kim
Publication date
01-07-2009
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 4/2009
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-008-9424-4

Other articles of this Issue 4/2009

Abdominal Radiology 4/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.